Product image of Klimicin, (Clindamycin) supplied by GNH India

Klimicin,

Active Ingredient:
Clindamycin
Origin:
EU

Klimicin, (Clindamycin)

Clindamycin, the active ingredient in Klimicin, is a lincosamide presented as an injectable solution for intramuscular and intravenous use. It treats bacterial infections of the skin, bone and joints, intra‑abdominal cavity and anaerobic organisms in adult patients.
GNH India supplies Klimicin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Sandoz Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Klimicin, a lincosamide antibiotic, is employed to manage infections caused by susceptible bacteria.

  • Skin and soft tissue infections: reduces bacterial load, alleviating redness, swelling and pain.
  • Bone and joint infections: eradicates pathogens in osteomyelitis and septic arthritis, supporting tissue recovery.
  • Intra‑abdominal infections: combats mixed aerobic and anaerobic flora, helping resolve peritonitis and abscesses.
  • Anaerobic infections: targets obligate anaerobes in deep‑seated infections, preventing spread and complications.

How It Works

  • Clindamycin binds to the 50S subunit of bacterial ribosomes, inhibiting the translocation step of protein synthesis. This action prevents the formation of peptide bonds, halting bacterial growth and leading to a bacteriostatic effect against susceptible Gram‑positive and anaerobic organisms.

Side Effects

Clindamycin may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, often transient.
  • Abdominal pain: cramping or discomfort.
  • Rash: skin redness or itching.
  • Injection site pain: soreness at the administration site.
  • Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects

  • Clostridioides difficile‑associated colitis: severe watery diarrhea, possibly with fever.
  • Anaphylaxis: rapid onset of hives, swelling, airway compromise.
  • Hepatotoxicity: elevated liver enzymes or jaundice.
  • Neutropenia: reduced white blood cell count, increasing infection risk.
  • Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
  • Pseudomembranous colitis: inflammation of the colon with characteristic plaques.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess renal function: adjust dosing in severe impairment.
  • Monitor hepatic function: watch for transaminase elevation.
  • Avoid use in patients with known hypersensitivity to clindamycin or other lincosamides.
  • Use with caution in pregnant or breastfeeding women: limited safety data available.
  • Consider risk of C. difficile infection: monitor for severe diarrhea.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Clindamycin can interact with several medications, requiring attention to the level of risk.

Major Interactions (Avoid)

  • Erythromycin: antagonistic effect on bacterial protein synthesis.
  • Neuromuscular blocking agents: potentiation of muscle relaxation, risking respiratory depression.
  • Strong CYP3A4 inhibitors: increased clindamycin plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
  • Oral contraceptives: potential reduction in efficacy, advise backup contraception.
  • Other macrolides: additive gastrointestinal side effects, monitor tolerance.

Frequently Asked Questions

Klimicin contains clindamycin and is used to treat bacterial infections such as skin and soft‑tissue infections, bone and joint infections, intra‑abdominal infections, and anaerobic infections. It is administered by intramuscular or intravenous injection under the direction of a qualified prescriber.

Clindamycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking the translocation step required for peptide chain formation. This halts bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive and anaerobic organisms.

The dosing regimen for Klimicin is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal and hepatic function, and route of administration. Only a qualified health professional should set the dose.

Safety data for clindamycin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To order Klimicin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Compared with beta‑lactam antibiotics, clindamycin offers good activity against anaerobes and certain resistant Gram‑positive organisms. It is often chosen when patients have beta‑lactam allergies or when anaerobic coverage is essential, but it lacks the broad Gram‑negative spectrum of some cephalosporins.

Klimicin should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Use aseptic technique when preparing the injectable solution, and discard any solution that appears discolored or contains particles.

Klimicin is given by intramuscular or intravenous injection. The exact route, infusion rate, and dilution volume are determined by the prescriber based on the infection type and patient condition. Administration should follow aseptic technique and institutional protocols.

Serious risks include Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, liver enzyme elevation, neutropenia, and rare severe skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions and advised to seek immediate medical attention if they occur.

Klimicin should not be used in individuals with a known hypersensitivity to clindamycin, lincomycin, or other lincosamides. Caution is also advised for patients with a history of severe colitis, significant hepatic impairment, or those taking interacting medications without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clindamycin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT